New Drug Applications

Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA

7 years ago
by David Miller
959 Views
Written by David Miller

SOLANA BEACH, Calif., March 14, 2019 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has submitted its response to the U.S….Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts
[mwai_chat window="true" fullscreen="true"]